Posted: February 14, 2008

VeruTEK Enters Into R&D Agreement with the National Risk Management Laboratory of the EPA

(Nanowerk News) VeruTEK Technologies, Inc. and the U.S. Environmental Protection Agency, Office of Research and Development’s National Risk Management Research Laboratory, announced today that they have entered into a cooperative research and development agreement. Under this agreement the parties will jointly develop green chemistry solutions and implementation technologies for environmental remediation. In addition, VeruTEK will be granted an exclusive license for the commercial use of any jointly developed solutions or technology.
John Collins, Ph.D., President and CEO of VeruTEK, said, “This partnership with the EPA furthers our focus as one of the first enviroceutical companies to develop, formulate, and distribute green chemistry solutions and implementation technologies that remedy and eliminate the toxic effects of chemical waste in the environment.”
The National Risk Management Research Laboratory (NRMRL) of the U.S. Environmental Protection Agency has performed substantial research and development with respect to remediating and destroying various organic and inorganic environmental toxins to prevent and reduce pollutant risks that threaten human health and the environment.
Sally Gutierrez, Director of the NRMRL, added, “The combination of our advanced scientific skills, especially in the field of green synthesis of safe nanoparticles, with VeruTEK’s expertise in the use of green chemistry for soil remediation and water and wastewater treatment technologies, will enable us together to make advancements in green environmental applications that can be utilized by both the private and public sectors.”
About VeruTEK Technologies, Inc.
VeruTEK (VTKT.OB) provides proprietary, patent-pending, green nanotechnology solutions for cleaning up the environment. For more information, please visit
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Source: VeruTEK Technologies
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: